For the Quarter Ending June 2023

North America:

In the United States, Levofloxacin Hemihydrate prices saw a 1.70 percent increase in June compared to April. The US manufacturing PMI (Purchasing Managers Index) declined to 46.3 in June, down from 48.4 in May and 47.1 in April. This indicated limited inventories among market suppliers and traders, coupled with supplier delivery delays to meet consumer demand, which bolstered Levofloxacin Hemihydrate prices. Additionally, growing market optimism stemmed from heightened consumer interest and supply shortages, prompting traders to raise their prices and focus on restocking. The consumer price index (CPI), a measure of inflation, rose by 0.2% in June, up from 0.1% in May, suggesting a moderation in June's inflation due to a US Federal Reserve interest rate hike. Despite the lower inflation rate, prices remained elevated, hinting at potential rate hikes in the third quarter. Import momentum remained steady, providing support to the Levofloxacin Hemihydrate market in the second quarter.

Asia Pacific:

In China, Levofloxacin Hemihydrate prices increased by 0.99 percent in June compared to April levels. Throughout the second quarter, Levofloxacin Hemihydrate prices remained elevated due to rising demand from end consumers and reduced inventories among market providers. Higher upstream costs and inventory restocking to meet future demand further bolstered the strength of the Levofloxacin Hemihydrate market. China's official manufacturing Purchasing Managers' Index settled at 49.0 in June, down from 48.8 in May and 49.2 in April, signaling a third consecutive month of reduced factory activity and lower production. This led to inventory shortages amid a positive demand outlook, maintaining high prices. Additionally, ongoing plant operations and increased inquiries from importers and traders resulted in higher production costs in the domestic market, contributing to elevated Levofloxacin Hemihydrate prices in China.

Get Real Time Prices of Levofloxacin Hemihydrate: https://www.chemanalyst.com/Pricing-data/levofloxacin-hemihydrate-1401

Europe:

In Germany, Levofloxacin Hemihydrate prices increased by 2.04 percent in June compared to April levels. The main drivers of higher price realization in the second quarter were rising domestic demand and adequate supplies among domestic merchants. Furthermore, the German market benefited from increased production in exporting countries in response to demand and elevated energy prices. Germany's manufacturing Purchasing Managers Index (PMI) declined to 41 in June, down from 43.2 in May and 44.5 in April, indicating decreased business activity, reduced inventories among market traders and suppliers, and shipment delays to meet demand, all contributing to higher Levofloxacin Hemihydrate prices. Increasing demand from the end-use sector further fueled the upward price trend. Additionally, inflation rose by 6.4% in June, and energy prices increased by 3%, resulting in higher costs for businesses relying on Active Pharmaceutical Ingredients (APIs), consequently leading to elevated Levofloxacin Hemihydrate prices.


About Us:

ChemAnalyst is a subsidiary of TechSci Research, which was established in 2008, and has been providing exceptional management consulting to its clients across the globe for over a decade now. For the past four years, ChemAnalyst has been a prominent provider of Chemical commodity prices in more than 15 countries. We are a team of more than 100 Chemical Analysts who are committed to provide in-depth market insights and real-time price movement for 300+ chemical and petrochemical products. ChemAnalyst has reverberated as a preferred pricing supplier among Procurement managers and Strategy professionals worldwide. On our platform, we provide an algorithm-based subscription where users can track and compare years of historical data and prices based on grades and incoterms (CIF, CFR, FOB, & EX-Works) in just one go.